301569 · SZSE
联亚药业 (301569) IPO Dates & Offering Details
Listing
Milestone date7 days agoMarket date context: Asia/Shanghai. Check the source for the exact release time.
Expected date · Source verifiedExpected date has passed; status unconfirmed
- Offer price
- ¥7
- Shares offered
- 133.74M shares
- Reported proceeds
- ¥936.18M
- First trading day
- 2026-10-15
Original Disclosure & Evidence
Expected date stated in the source; subject to subsequent disclosures.
Evidence reading notes
The passages below are located within the saved evidence summary by date, share or restriction terms. Summaries are not verbatim quotations or independent verification. Refer to the original document for complete terms.
- Dates in the evidence
- 巨潮2026-10-14上市公告书，发行人为南通联亚药业股份有限公司，证券简称联亚药业、代码301569。
Read the full saved evidence summary
巨潮2026-10-14上市公告书，发行人为南通联亚药业股份有限公司，证券简称联亚药业、代码301569。PDF第10页明确上市地点为深圳证券交易所（SZSE）、上市时间2026-10-15；第10页公开发行新股13373.9563万股，即133,739,563股。第4页发行价格7.00元/股；第37页总募集资金93617.69万元，即人民币936,176,900元，使用总额而非扣费净额。本次发行全部为新股，不将上市初期可流通股数误作发行股数；固定价格发行未填价格区间。原文为上市时间公告，未另证实际成交，date_status保留expected；万元转元乘10,000并保留来源舍入精度。- Evidence verified
- Oct 20, 2026, 10:42 AM
- Updated at
- Oct 20, 2026, 10:42 AM
What this record establishes
This is a recorded listing milestone. A first trading date does not establish the start or end of every shareholder's lock-up; the applicable agreement controls.
Date status: expected, as stated in the source. A past date is not automatic evidence of completion.
Additional items to verify
- No linked verified lock-up window is available here. This does not mean no lock-up applies.
- Review business and revenue, use of proceeds, dilution, ownership, underwriters and risk factors in the source prospectus.